| KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study BD Shah, A Ghobadi, OO Oluwole, AC Logan, N Boissel, RD Cassaday, ... The Lancet 398 (10299), 491-502, 2021 | 404 | 2021 |
| Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease S Van de Veire, I Stalmans, F Heindryckx, H Oura, A Tijeras-Raballand, ... Cell 141 (1), 178-190, 2010 | 303 | 2010 |
| Crosstalk between ROR1 and the Pre-B Cell Receptor Promotes Survival of t (1; 19) Acute Lymphoblastic Leukemia VT Bicocca, BH Chang, BK Masouleh, M Muschen, MM Loriaux, ... Cancer Cell 22 (5), 656-667, 2012 | 197 | 2012 |
| Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1+ leukemia T Schmidt, BK Masouleh, S Loges, S Cauwenberghs, P Fraisl, C Maes, ... Cancer cell 19 (6), 740-753, 2011 | 164 | 2011 |
| The adult stem cell marker Musashi‐1 modulates endometrial carcinoma cell cycle progression and apoptosis via Notch‐1 and p21WAF1/CIP1 M Götte, B Greve, R Kelsch, H Müller‐Uthoff, K Weiss, ... International journal of cancer 129 (8), 2042-2049, 2011 | 124 | 2011 |
| Anti-leukemic activity and tolerability of anti-human CD47 monoclonal antibodies EC Pietsch, J Dong, R Cardoso, X Zhang, D Chin, R Hawkins, T Dinh, ... Blood cancer journal 7 (2), e536-e536, 2017 | 105 | 2017 |
| Mechanistic rationale for targeting the unfolded protein response in pre-B acute lymphoblastic leukemia B Kharabi Masouleh, H Geng, C Hurtz, LN Chan, AC Logan, MS Chang, ... Proceedings of the National Academy of Sciences 111 (21), E2219-E2228, 2014 | 102 | 2014 |
| Inhibition of IRE1α-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia H Sun, DC Lin, X Guo, BK Masouleh, S Gery, Q Cao, S Alkan, T Ikezoe, ... Oncotarget 7 (14), 18736, 2016 | 85 | 2016 |
| SOX4 enables oncogenic survival signals in acute lymphoblastic leukemia P Ramezani-Rad, H Geng, C Hurtz, LN Chan, Z Chen, H Jumaa, ... Blood, The Journal of the American Society of Hematology 121 (1), 148-155, 2013 | 81 | 2013 |
| Role of the heparan sulfate proteoglycan syndecan-1 (CD138) in delayed-type hypersensitivity BK Masouleh, GB Ten Dam, MK Wild, R Seelige, J van der Vlag, AL Rops, ... The Journal of Immunology 182 (8), 4985-4993, 2009 | 74 | 2009 |
| Accelerated telomere shortening in peripheral blood lymphocytes after occupational polychlorinated biphenyls exposure S Ziegler, T Schettgen, F Beier, S Wilop, N Quinete, A Esser, ... Archives of toxicology 91, 289-300, 2017 | 57 | 2017 |
| Quantification of circulating endothelial progenitor cells in human peripheral blood: establishing a reliable flow cytometry protocol BK Masouleh, A Baraniskin, W Schmiegel, R Schroers Journal of immunological methods 357 (1-2), 38-42, 2010 | 54 | 2010 |
| Drugging the unfolded protein response in acute leukemias B Kharabi Masouleh, E Chevet, J Panse, E Jost, M O’Dwyer, ... Journal of hematology & oncology 8, 1-10, 2015 | 33 | 2015 |
| Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the … ADJ Pearson, C Rossig, C Mackall, NN Shah, A Baruchel, G Reaman, ... European Journal of Cancer 160, 112-133, 2022 | 28 | 2022 |
| Identification of the adapter molecule MTSS1 as a potential oncogene-specific tumor suppressor in acute myeloid leukemia M Schemionek, B Kharabi Masouleh, Y Klaile, U Krug, K Hebestreit, ... PloS one 10 (5), e0125783, 2015 | 28 | 2015 |
| Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external … BD Shah, A Ghobadi, OO Oluwole, AC Logan, N Boissel, RD Cassaday, ... Journal of hematology & oncology 15 (1), 170, 2022 | 25 | 2022 |
| A three-gene expression-based risk score can refine the European LeukemiaNet AML classification S Wilop, WC Chou, E Jost, M Crysandt, J Panse, MK Chuang, ... Journal of hematology & oncology 9, 1-10, 2016 | 20 | 2016 |
| Infliction of proteotoxic stresses by impairment of the unfolded protein response or proteasomal inhibition as a therapeutic strategy for mast cell leukemia T Wilhelm, F Bick, K Peters, V Mohta, B Tirosh, JB Patterson, ... Oncotarget 9 (3), 2984, 2018 | 19 | 2018 |
| Telomere dynamics in patients with del (5q) MDS before and under treatment with lenalidomide F Beier, BK Masouleh, G Buesche, MSV Ferreira, RK Schneider, P Ziegler, ... Leukemia Research 39 (11), 1292-1298, 2015 | 19 | 2015 |
| Three-year results from phase I of ZUMA-4: KTE-X19 in pediatric relapsed/refractory acute lymphoblastic leukemia AS Wayne, V Huynh, N Hijiya, RH Rouce, PA Brown, J Krueger, CL Kitko, ... Haematologica 108 (3), 747, 2023 | 17 | 2023 |
